EichorEICHOR
Study identifier: NCT07524946 Synced from ClinicalTrials.gov · August 05, 2026
● Study status: Recruiting

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

Condition: Acne Vulgaris  ·  Sponsor: Bausch Health Americas, Inc.

PhasePhase 4
Planned participants100
Who can joinAll sexes, 9 Years to 11 Years
Healthy volunteersNo

About this study

This study is to evaluate the safety, pharmacokinetics, and treatment effect for topically applied CABTREO lotion in pediatric participants ages 9 to 11 years, 11 months with Acne Vulgaris.

This description comes directly from the study's public registry record.

Talk to the study team

Emily N Hughes, MACPR  ·  731-415-3174  ·  Emily.Hughes@BauschHealth.com

Alison Magnotti-Nagel, CCRA  ·  908-541-8664  ·  Alison.Magnotti-Nagel@bauschhealth.com

Always discuss trial participation with your own doctor first.

Locations (15)

Dermatology Trial AssociatesBryant, Arkansas, United StatesRecruiting
Northwest Arkansas Clinical Trials CenterRogers, Arkansas, United StatesRecruiting
Center for Dermatology Clinical ResearchFreemont, California, United StatesRecruiting
Ablon Skin Institute and Research CenterManhattan Beach, California, United StatesRecruiting
Ziaderm Research, LLCNorth Miami Beach, Florida, United StatesRecruiting
Clinical Research Trials of Florida, IncTampa, Florida, United StatesRecruiting
DS Research of Kentucky, LLCLouisville, Kentucky, United StatesRecruiting
Michigan Center for Skin Care ResearchClinton Township, Michigan, United StatesRecruiting
JDR Dermatology ResearchLas Vegas, Nevada, United StatesRecruiting
DermResearchCenter of New YorkStony Brook, New York, United StatesRecruiting
Vitality Clinical Trials, LLCWoodbury, New York, United StatesRecruiting
Flourish Research Acquisition, LLCApex, North Carolina, United StatesNot Yet Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →